Introduction of Hib vaccine into national immunization programmes: a descriptive analysis of global trends (Q40176358)

18 September 2017

Introduction of Hib vaccine into national immunization programmes: a descriptive analysis of global trends (English)

1 reference

18 September 2017

0 references

1 reference

2

Patrick L F Zuber

1 reference

18 September 2017

Isabelle A Rossi

1

1 reference

18 September 2017

Laure Dumolard

series ordinal

3

1 reference

18 September 2017

Damian G Walker

series ordinal

4

1 reference

18 September 2017

James Watt

series ordinal

5

1 reference

18 September 2017

language of work or name

English

0 references

publication date

15 August 2007

1 reference

18 September 2017

1 reference

18 September 2017

25

1 reference

18 September 2017

41

1 reference

18 September 2017

7075-7080

1 reference

Where and why are 10 million children dying every year?

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

The Gambian Haemophilus influenzae type b vaccine trial: what does it tell us about the burden of Haemophilus influenzae type b disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Evaluation of vaccines for the prevention of pneumonia in children in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Evidenced-based decision making about Hib vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

How many child deaths can we prevent this year?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

The UK Hib vaccine experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four 'newly adopting' countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Development, evaluation and implementation of Haemophilus influenzae type b vaccines for young children in developing countries: current status and priority actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

The introduction of new vaccines into developing countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Introducing GAVI and the Global Fund for Children's Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

The impact of conjugate vaccine on carriage of Haemophilus influenzae type b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Haemophilus influenzae type b disease and vaccination in Europe: lessons learned

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Impact of anti-Hib conjugate vaccine on the incidence of Haemophilus influenzae meningitis in Brazil's Federal District: results of a three-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

The introduction of new vaccines into developing countries II. Vaccine financing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Is vaccination against hepatitis B efficient? A review of world literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.058

10.1016/J.VACCINE.2007.07.058

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference